Free Medical Devices WebinarsSign up to watch our free medical devices industry webinars.
Get the Medical Devices newsletterSign up to our free email to get all the latest medical devices news.Asuragen, Inc has entered into an agreement with Biogen Idec to identify a potential companion diagnostic test. This test may be used to select patients likely to respond to a Biogen Idec therapeutic candidate in clinical development.
Subscribe to our email newsletter
“The integrated drug-diagnostic co-development strategy being pursued by Biogen Idec and Asuragen has enormous potential to help physicians identify patients that will benefit from specific cancer treatments, and will be another step towards delivering on the promise of personalized medicine,” said Matt Winkler, CEO of Asuragen. “We look forward to leveraging our long history and broad expertise in biomarker discovery, pharmacogenomic services, and diagnostic development capabilities for this project.”